FDA OK's Valeant toenail fungus drug Jublia
This article was originally published in Scrip
Executive Summary
After initially being rejected by the FDA, Valeant Pharmaceuticals won approval on 9 June to market Jublia (efinaconazole 10% topical solution) as the first topical triazole in the US for onychomycosis of the toenails.